InvestorsHub Logo
Followers 48
Posts 12047
Boards Moderated 0
Alias Born 09/12/2017

Re: Monroe1 post# 221763

Tuesday, 07/11/2023 3:01:48 PM

Tuesday, July 11, 2023 3:01:48 PM

Post# of 233221

These results were achieved with just two doses of leronlimab, one dose at day 0 and a second dose at day 7.



Heres the link---

CytoDyn Files New Protocol with U.S. FDA for 4 Doses of Leronlimab for Critically Ill COVID-19 Patients with the Objective to Duplicate or Surpass 82% Survival Benefit with P-Value of 0.0233 Originally Achieved from Two Weeks of Treatment in CD12 Trial With 2 Doses
April 01, 2021 06:00 ET
| Source: CytoDyn Inc.

https://www.globenewswire.com/news-release/2021/04/01/2203092/19782/en/CytoDyn-Files-New-Protocol-with-U-S-FDA-for-4-Doses-of-Leronlimab-for-Critically-Ill-COVID-19-Patients-with-the-Objective-to-Duplicate-or-Surpass-82-Survival-Benefit-with-P-Value-o.html

Got this link too---

Nobel Prize contender. NP, my money is on him.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News